Comerica Bank trimmed its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 20.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 59,966 shares of the company's stock after selling 15,773 shares during the period. Comerica Bank's holdings in Astera Labs were worth $9,976,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Assetmark Inc. grew its holdings in Astera Labs by 374.1% during the 3rd quarter. Assetmark Inc. now owns 128 shares of the company's stock worth $25,000 after acquiring an additional 101 shares in the last quarter. Hilltop National Bank lifted its position in shares of Astera Labs by 100.0% during the fourth quarter. Hilltop National Bank now owns 200 shares of the company's stock valued at $33,000 after buying an additional 100 shares during the last quarter. Aventura Private Wealth LLC purchased a new stake in shares of Astera Labs during the fourth quarter valued at about $33,000. National Bank of Canada FI lifted its position in shares of Astera Labs by 159.0% during the third quarter. National Bank of Canada FI now owns 202 shares of the company's stock valued at $39,000 after buying an additional 124 shares during the last quarter. Finally, Wexford Capital LP purchased a new stake in shares of Astera Labs during the third quarter valued at about $39,000. 60.47% of the stock is currently owned by institutional investors.
Insider Activity at Astera Labs
In other Astera Labs news, CEO Jitendra Mohan sold 325,693 shares of the firm's stock in a transaction that occurred on Friday, April 17th. The shares were sold at an average price of $172.14, for a total transaction of $56,064,793.02. Following the completion of the transaction, the chief executive officer directly owned 4,079,322 shares of the company's stock, valued at approximately $702,214,489.08. This trade represents a 7.39% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of the firm's stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $107.61, for a total transaction of $19,692,630.00. Following the transaction, the director directly owned 319,863 shares of the company's stock, valued at $34,420,457.43. This represents a 36.39% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,064,888 shares of company stock worth $150,764,723 in the last ninety days. 12.50% of the stock is owned by company insiders.
Astera Labs Stock Up 7.4%
Shares of Astera Labs stock opened at $196.85 on Thursday. The firm has a market capitalization of $33.72 billion, a P/E ratio of 161.35, a PEG ratio of 3.87 and a beta of 1.78. The company has a 50 day moving average price of $137.76 and a 200 day moving average price of $153.10. Astera Labs, Inc. has a 52 week low of $62.31 and a 52 week high of $262.90.
Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, beating the consensus estimate of $0.51 by $0.07. The firm had revenue of $270.58 million during the quarter, compared to analyst estimates of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. Astera Labs's revenue was up 91.8% on a year-over-year basis. During the same period last year, the firm posted $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, research analysts anticipate that Astera Labs, Inc. will post 1.48 earnings per share for the current fiscal year.
Analysts Set New Price Targets
Several research firms have commented on ALAB. Loop Capital began coverage on shares of Astera Labs in a research report on Thursday, March 5th. They set a "buy" rating and a $250.00 price target for the company. Royal Bank Of Canada reissued an "outperform" rating and set a $250.00 price target on shares of Astera Labs in a research report on Tuesday, April 21st. Citigroup initiated coverage on shares of Astera Labs in a research report on Thursday, April 2nd. They set a "buy" rating and a $200.00 price target for the company. UBS Group initiated coverage on shares of Astera Labs in a research report on Tuesday, April 21st. They issued a "neutral" rating and a $180.00 price objective for the company. Finally, Barclays set a $165.00 price objective on shares of Astera Labs in a research report on Thursday, January 15th. Fifteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $199.74.
Check Out Our Latest Research Report on ALAB
About Astera Labs
(
Free Report)
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
See Also
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
SpaceX has quietly filed to go public later this year. Ahead of what's expected to be the largest IPO of all time, there are seven space stocks that you can buy today that are positioned to benefit from accelerating space commercialization in 2026.
These seven companies are shaping the next phase of the space economy—from launch leaders and satellite networks to data, defense, and in-space infrastructure.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.